Skip to content

A clinical study to see the effectiveness of marma chikitsa in pain and range of movements in subjects diagnosed of apabahuka(frozen shoulder)

Clinical study on the effectiveness of marma chikitsa in apabahuka

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042454
Enrollment
30
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)SUBJECTS FULFILLING THE DIAGNOSTIC CRITERIA a.Bahupraspanditahara (restriction in movements of shoulder joint) b.Shoola 2)Subjects who are willing to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Subjects with any fracture,dislocation of shoulder joint and cervical spine or any congenital deformity or any trauma. 2)Pregnant woman and lactating mother 3)Subjects diagnosed of neoplasms and infective conditions 4)Subjects taking analgesics

Design outcomes

Primary

MeasureTime frame
Signs and symptoms of apabahuka will be assesed by giving suitable scoring at two intervals namely before treatment on 1st day and after treatment on 7th dayTimepoint: Signs and symptoms of apabahuka will be assesed by giving suitable scoring at two intervals namely before treatment on 1st day and after treatment on 7th day

Secondary

MeasureTime frame
To asses the improvement in the quality of lifeTimepoint: Improvement in the quality of life will be assesed for 7 days

Countries

India

Contacts

Public ContactDr ASHVINIKUMAR M

RGUHS

ashvinipanchakarma@gmail.com9448705660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026